CTLA4 and melanoma: As this example showed that macrophage membrane-coated Chl. (M-Chl) realized targeted delivery of DOX, antibodies targeting T-lymphocyte-associated protein 4 (CTLA-4), and anti-CTLA-4, for improved chemotherapy and immunotherapy of melanoma (Fig. 3D) (Gao et al.2022).